Funding analysts at Evercore ISI assumed protection on shares of Xponential Health (NYSE:XPOF – Get Score) in a analysis observe issued on Monday, The Fly reviews. The agency set an “outperform” ranking and a $34.00 worth goal on the inventory. Evercore ISI’s worth goal would point out a possible upside of 68.65% from the inventory’s present worth.
A number of different equities analysts have additionally commented on XPOF. Robert W. Baird raised their goal worth on shares of Xponential Health from $26.00 to $28.00 in a report on Monday. Roth Capital initiated protection on shares of Xponential Health in a analysis observe on Tuesday, November sixteenth. They issued a “purchase” ranking and a $29.00 worth goal on the inventory. Raymond James decreased their worth goal on shares of Xponential Health from $28.00 to $27.00 and set a “strong-buy” ranking on the inventory in a analysis observe on Friday, March 4th. Lastly, Zacks Funding Analysis downgraded shares of Xponential Health from a “strong-buy” ranking to a “maintain” ranking in a analysis observe on Wednesday, March ninth. One funding analyst has rated the inventory with a maintain ranking, 9 have assigned a purchase ranking and one has issued a robust purchase ranking to the corporate’s inventory. In line with MarketBeat, Xponential Health presently has a median ranking of “Purchase” and a median goal worth of $24.15.
NYSE:XPOF traded up $0.31 throughout mid-day buying and selling on Monday, reaching $20.16. 8,144 shares of the corporate’s inventory have been exchanged, in comparison with its common quantity of 166,000. Xponential Health has a one yr low of $9.87 and a one yr excessive of $24.73. The enterprise’s fifty day shifting common is $18.41. The corporate has a debt-to-equity ratio of 80.16, a fast ratio of 0.86 and a present ratio of 0.95.
Xponential Health (NYSE:XPOF – Get Score) final launched its quarterly earnings outcomes on Thursday, March third. The corporate reported ($0.21) EPS for the quarter, hitting analysts’ consensus estimates of ($0.21). Promote-side analysts anticipate that Xponential Health will publish 0.84 EPS for the present yr.
A number of giant buyers have just lately added to or decreased their stakes within the firm. Charles Schwab Funding Administration Inc. elevated its stake in shares of Xponential Health by 2.8% within the 4th quarter. Charles Schwab Funding Administration Inc. now owns 24,522 shares of the corporate’s inventory valued at $502,000 after buying a further 658 shares within the final quarter. Citigroup Inc. elevated its stake in shares of Xponential Health by 119.8% within the 4th quarter. Citigroup Inc. now owns 2,372 shares of the corporate’s inventory valued at $48,000 after buying a further 1,293 shares within the final quarter. Strs Ohio purchased a brand new stake in shares of Xponential Health within the third quarter valued at $26,000. Squarepoint Ops LLC elevated its stake in shares of Xponential Health by 3.3% within the 4th quarter. Squarepoint Ops LLC now owns 103,274 shares of the corporate’s inventory valued at $2,111,000 after buying a further 3,274 shares within the final quarter. Lastly, New York State Frequent Retirement Fund purchased a brand new stake in shares of Xponential Health within the 4th quarter valued at $89,000. Institutional buyers personal 21.40% of the corporate’s inventory.
Xponential Health Firm Profile (Get Score)
Xponential Health Inc is a curator of boutique health manufacturers throughout a number of verticals. The corporate constructed and curated a diversified platform of boutique health manufacturers spanning throughout verticals together with Pilates, indoor biking, barre, stretching, rowing, dancing, boxing, operating and yoga. Its portfolio of manufacturers contains Membership Pilates, CycleBar, StretchLab, Row Home, AKT, YogaSix and STRIDE.
Additional Studying
This on the spot information alert was generated by narrative science expertise and monetary knowledge from MarketBeat with the intention to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial workforce previous to publication. Please ship any questions or feedback about this story to [email protected]
Must you make investments $1,000 in Xponential Health proper now?
Earlier than you take into account Xponential Health, you may need to hear this.
MarketBeat retains observe of Wall Avenue’s top-rated and greatest performing analysis analysts and the shares they advocate to their shoppers every day. MarketBeat has recognized the 5 shares that prime analysts are quietly whispering to their shoppers to purchase now earlier than the broader market catches on… and Xponential Health wasn’t on the listing.
Whereas Xponential Health at the moment has a “Purchase” ranking amongst analysts, top-rated analysts consider these 5 shares are higher buys.